ConductScience.org, home

Paper36034865

Engaging plasticity: Differentiation therapy in solid tumors.

Bar-Hai N and 1 other. Front Pharmacol, 2022. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Engaging plasticity: Differentiation therapy in solid tumors. Papers, record 36034865. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36034865

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Engaging plasticity: Differentiation therapy in solid tumors.
PubMed
Journal
Front Pharmacol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.95
iCite
Revised in PubMed
2022-08-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bar-Hai NNeta
2Ishay-Ronen DDana

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References169

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115717297Histone deacetylation in epigenetics: an attractive target for anticancer therapy.Med Res Rev2005https://conductscience.org/library/papers/15717297PubMed
222901808The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.Cell2012https://conductscience.org/library/papers/22901808PubMed
327832522Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells.Mol Neurobiol2017https://conductscience.org/library/papers/27832522PubMed
423014973Retinoic acid regulates commitment of undifferentiated mesenchymal stem cells into osteoblasts and adipocytes.J Bone Miner Metab2013https://conductscience.org/library/papers/23014973PubMed
511282573Histone acetylation and the cell-cycle in cancer.Front Biosci2001https://conductscience.org/library/papers/11282573PubMed
619169796EMT, the cytoskeleton, and cancer cell invasion.Cancer Metastasis Rev2009https://conductscience.org/library/papers/19169796PubMed
723201163Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.Cancer Cell2012https://conductscience.org/library/papers/23201163PubMed
817612559The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells.J Surg Res2007https://conductscience.org/library/papers/17612559PubMed
921612856Retinoic acid-induced Smad3 expression is required for the induction of osteoblastogenesis of mesenchymal stem cells.Differentiation2011https://conductscience.org/library/papers/21612856PubMed
1023972859Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition.Biophys J2013https://conductscience.org/library/papers/23972859PubMed
1114612500Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer.Cancer Res2003https://conductscience.org/library/papers/14612500PubMed
1222576165To differentiate or not--routes towards metastasis.Nat Rev Cancer2012https://conductscience.org/library/papers/22576165PubMed
1332083171Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms.Sci Adv2020https://conductscience.org/library/papers/32083171PubMed
1433675037The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma.J Pathol2021https://conductscience.org/library/papers/33675037PubMed
159734398Differentiation and reversal of malignant changes in colon cancer through PPARgamma.Nat Med1998https://conductscience.org/library/papers/9734398PubMed
1634847378Distinct contributions of partial and full EMT to breast cancer malignancy.Dev Cell2021https://conductscience.org/library/papers/34847378PubMed
1711731433The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.Cancer Res2001https://conductscience.org/library/papers/11731433PubMed
1829079737miR-1199-5p and Zeb1 function in a double-negative feedback loop potentially coordinating EMT and tumour metastasis.Nat Commun2017https://conductscience.org/library/papers/29079737PubMed
1917417771Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells.Int J Cancer2007https://conductscience.org/library/papers/17417771PubMed
2026077423Small molecule inhibitors of EZH2: the emerging translational landscape.Epigenomics2015https://conductscience.org/library/papers/26077423PubMed

See all 169 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42491051Drosophila neural stem cell division and human tumorigenesis: fail to divide (asymmetrically) and tumors…will conquer?Front Cell Dev Biol2026https://conductscience.org/library/papers/42491051PubMed
42236828When effective anticancer therapies are, in fact, destabilizing the tumor's Group Phenotypic Composition.NPJ Precis Oncol2026https://conductscience.org/library/papers/42236828PubMed
41372554Pleiotropic effects of all-trans retinoic acid in attenuating the hallmarks of colorectal cancer- challenges and scope of differentiation therapy.Cancer Gene Ther2026https://conductscience.org/library/papers/41372554PubMed
41318947Differentiation Treatment Applied to Lung Cancer Model Reduces Pathogenic Traits in Vitro.Adv Biol (Weinh)2026https://conductscience.org/library/papers/41318947PubMed
41225636Neurogenic inducers inhibit the proliferation of pancreatic cancer by promoting tumor cell transdifferentiation.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/41225636PubMed
40426233Ephrin-A5 or EphA7 stimulation is anti-proliferative for human rhabdomyosarcoma in vitro.Skelet Muscle2025https://conductscience.org/library/papers/40426233PubMed
40413503Drug-induced tolerant persisters in tumor: mechanism, vulnerability and perspective implication for clinical treatment.Mol Cancer2025https://conductscience.org/library/papers/40413503PubMed
40259075Tumor heterogeneity in retinoblastoma: a literature review.Cancer Metastasis Rev2025https://conductscience.org/library/papers/40259075PubMed
40076613Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/40076613PubMed
39710702Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer.J Transl Med2024https://conductscience.org/library/papers/39710702PubMed
39363281Comprehensive transcriptomic analysis identifies three distinct subtypes of pituitary adenomas: insights into tumor behavior, prognosis, and stem cell characteristics.J Transl Med2024https://conductscience.org/library/papers/39363281PubMed
39273076Class Effect Unveiled: PPARγ Agonists and MEK Inhibitors in Cancer Cell Differentiation.Cells2024https://conductscience.org/library/papers/39273076PubMed
38482207Editorial: Integrating transcriptional modulation in systemic tumor therapy.Front Oncol2024https://conductscience.org/library/papers/38482207PubMed
38457060Initiation of Cancer: The Journey From Mutations in Somatic Cells to Epigenetic Changes in Tissue-resident VSELs.Stem Cell Rev Rep2024https://conductscience.org/library/papers/38457060PubMed
38273846Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity.Front Oncol2023https://conductscience.org/library/papers/38273846PubMed
38201607Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance.Cancers (Basel)2023https://conductscience.org/library/papers/38201607PubMed
38158755Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology.Mol Oncol2024https://conductscience.org/library/papers/38158755PubMed
37858275Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells.Clin Epigenetics2023https://conductscience.org/library/papers/37858275PubMed
37628798A Novel Transgenic Mouse Model Implicates Sirt2 as a Promoter of Hepatocellular Carcinoma.Int J Mol Sci2023https://conductscience.org/library/papers/37628798PubMed
37625115Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma.Neuro Oncol2024https://conductscience.org/library/papers/37625115PubMed

Download CSV of cited by

Genes29

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CDH21000PubTator's text mininghttps://conductscience.org/library/genes/1000NCBI Gene
CYP26A11592PubTator's text mininghttps://conductscience.org/library/genes/1592NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
EZH22146PubTator's text mininghttps://conductscience.org/library/genes/2146NCBI Gene
HDAC99734PubTator's text mininghttps://conductscience.org/library/genes/9734NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
MAP2K75609PubTator's text mininghttps://conductscience.org/library/genes/5609NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene
PML5371PubTator's text mininghttps://conductscience.org/library/genes/5371NCBI Gene
PPARG5468PubTator's text mininghttps://conductscience.org/library/genes/5468NCBI Gene
PRDM956979PubTator's text mininghttps://conductscience.org/library/genes/56979NCBI Gene
PRRT2112476PubTator's text mininghttps://conductscience.org/library/genes/112476NCBI Gene
PTPRK5796PubTator's text mininghttps://conductscience.org/library/genes/5796NCBI Gene

See all 29 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36034865

GET https://conductscience.org/api/papers/v1/36034865/references?page=2